SAN FRANCISCO, Oct. 26, 2023 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) announced one-year results from CLASP IID, the first randomized controlled trial that directly compares two ...
Edwards Lifesciences has received the US Food and Drug Administration (FDA) approval for its SAPIEN M3 mitral valve replacement system. It is said to be the first transcatheter therapy using a ...
Edwards’ Pascal and Abbott’s MitraClip TEER devices are cleared in the U.S. to repair the mitral valve in patients with mitral regurgitation. The condition occurs when the valve does not shut properly ...
NEW YORK, NY—Transcatheter edge-to-edge repair (TEER) with the Pascal system (Edwards Lifesciences) in patients with degenerative mitral regurgitation (MR) results in good early survival outcomes, ...
Philips' DeviceGuide software uses AI to create virtual 3D images to assist physicians during mitral valve repair procedures. This story was originally published on MedTech Dive. To receive daily news ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results